Novacyt completes acquisition of Southern Cross Diagnostics

Eli Lilly's Olumiant (baricitinib) receives positive European regulatory opinion for approval to treat adolescents with severe alopecia areata

Atrium Therapeutics launches as newly independent, publicly traded company

Innovent Biologics' Jaypirca approved in China for new indication

Gemma Biotherapeutics doses first parent in GB221 Phase 1/2 CHARISMA clinical trial

Neurizon Therapeutics doses first participant in NUZ-001 Regimen I HEALEY ALS Platform Trial

Melodia Therapeutics reports award of US patent covering MLD-151

Argo Biopharmaceutical to present BW-20805 Phase II interim data at AAAAI 2026 Annual Meeting

FDA accepts sNDA for MR-141 for the treatment of presbyopia

Bruker launches CellScape XR to advance clinical spatial proteomics

Charles River Laboratories to divest CDMO, Cell Solutions, and European discovery assets

GSK to acquire 35Pharma for USD950m to strengthen cardiopulmonary pipeline

SoftOx secures Irish approval for Phase 1 trial of SIS-02

Avid Bioservices opens new Early Phase Center of Excellence

OrthoTrophix completes patient enrolment in TPX-100 Phase 2b clinical trial